Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.

Mult Scler J Exp Transl Clin · 2021 · PMC8108088 · PMID 33996142

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Conclusion Dimethyl fumarate showed a trend towards reduction in T25FW but no evidence of clinically significant impact on EDSS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.